Understanding Ibrutinib Cll And The Elderly
Exploring Ibrutinib Cll And The Elderly reveals several interesting facts. Paul Barr, MD of the University of Rochester discusses recent data presented at the 58th Annual ASH Meeting & Exposition ...
Key Takeaways about Ibrutinib Cll And The Elderly
- Arnon Kater, MD, PhD, Professor of Internal Medicine in the Faculty of Medicine at the University of Amsterdam discusses new ...
- Jacqueline Barrientos, MD, MS, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, shares data from the Phase II ...
- A review of recent clinical trials investigating the role of
- Jennifer R. Brown, MD, PhD, and Alan Skarbnik, MD, highlight differences between the second-generation Bruton tyrosine kinase ...
- This video is part of the HMP Education content archive and may include previously accredited educational material. While this ...
Detailed Analysis of Ibrutinib Cll And The Elderly
Dr Tedeschi talks to ecancertv at ASH 2015 about using ... of 134 so who really it's an amazing drug and that would be my go to drug for an Jeffrey Jones, MD, MPH from the Ohio State University, Columbus, OH discusses the characteristics and mode of action of ...
William Wierda, MD, PhD, outlines the therapeutic options available to a patient with
Stay tuned for more updates related to Ibrutinib Cll And The Elderly.